Longevity assurance interventions, metabolic health and Alzheimer's Disease
Longevity assurance interventions, metabolic health and Alzheimer's Disease
批准号:
10418764
负责人:
Liou Sun
金额:
$49.27万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-09-01 至 2025-05-31
关键词:
3xTg-AD mouseAPP-PS1AddressAffectAgeAgingAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAmericanAmyloid beta-ProteinAnimal ModelAnimalsBehavioralBiological ModelsBiology of AgingBody Weight decreasedBrainChronologyCognitive agingComb animal structureDementiaDependenceDevelopmentDietary InterventionDiseaseDisease ProgressionDisease modelEffectivenessElderlyElectrophysiology (science)ExhibitsFoundationsFutureGenerationsGeneticGerontologyGlucoseGoalsHealthHealth Care CostsHomeostasisHumanIncidenceInsulinInsulin ResistanceInterventionInvestigationLaron SyndromeLeadLearningLipidsLongevityMalignant NeoplasmsMemoryMetabolicMetabolic dysfunctionMetabolic syndromeMetabolismMethionineMitochondriaModelingMolecularMusMutant Strains MiceMutationNerve DegenerationNeurodegenerative DisordersNeurosciencesNon-Insulin-Dependent Diabetes MellitusObesityOrganismOutcomePathologicPathologyPathway interactionsPharmaceutical PreparationsPharmacologyPhenotypePhysiologicalProcessPublic HealthRattusResearchRisk FactorsRodentRodent ModelSenile PlaquesSignal PathwaySomatotropinSomatotropin-Releasing HormoneTestingWorkYeastsabeta depositionage relatedaging brainanti agingbaby boomercost effectivediabetes riskdietarydietary restrictiondisease phenotypeepidemiology studygenetic manipulationhealthspanhormonal signalsimprovedinsulin sensitivitymiddle agemodel developmentmortalitymutantnervous system disordernovelnovel strategiespathological agingpreclinical studypreventresponsesymptom treatmentsynaptic functiontau Proteinstau aggregationtherapeutically effectivetherapy development
中文摘要
神经退行性疾病发病的年龄依赖性机制是
英文摘要
The mechanisms responsible for the age dependence of the onset of neurodegeneration are
unknown, which represents a fundamental problem both in neuroscience and biogerontology.
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
dementia, deposition of beta amyloid (Aβ) plaques, and neurofibrillary tau tangles. Despite
progress in developing treatments for the symptomatic relief of AD, most drugs only exhibit
marginal benefits and no cure currently exists. Epidemiological and preclinical studies provide
strong evidence that metabolic derangements including obesity, metabolic syndrome and type 2
diabetes constitute major risk factors for age-related diseases including dementia and AD but
the mechanisms involved remain to be elucidated.
The GH signaling functions as a central regulator of metabolism and energy use, and it
coordinates the physiological responses of the entire organism through hormonal signaling.
Mutant animals with reduced GH signaling are not only long-lived, but are protected against
age-associated decline in memory and learning. Methionine restriction has been shown
previously to extend lifespan and delay aging in both rats and mice, dramatically decrease body
weight and adiposity, and improve insulin sensitivity and ameliorate aging-associated alterations
in glucose and lipid homeostasis. Thus, combing delaying aging models with AD disease
models exhibiting various phenotypic effects provides a novel opportunity to develop new
models that will allow studies focused on the interaction between aging, metabolism, and
neurodegeneration.
Our proposed study will determine if suppression of the GH signaling and methionine
restriction will prevent development of behavioral, electrophysiological and histopathologic
abnormalities of AD phenotype can serve as a model to study the interaction of aging with AD,
providing a new level of analysis of the human brain in health and disease.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.18632/aging.202451
发表时间:
2020-12-28
期刊:
Aging
影响因子:
--
作者:
[Zhang F, Icyuz M, Bartke A, Sun LY]
通讯作者:
Sun LY
DOI:
10.3389/fendo.2020.579909
发表时间:
2020
期刊:
Frontiers in endocrinology
影响因子:
5.2
作者:
[Nagarajan A, Srivastava H, Jablonsky J, Sun LY]
通讯作者:
Sun LY
DOI:
10.3390/biomedicines11010104
发表时间:
2022-12-30
期刊:
Biomedicines
影响因子:
4.7
作者:
[]
通讯作者:
DOI:
10.1093/cdn/nzab134
发表时间:
2021-12
期刊:
Current developments in nutrition
影响因子:
4.8
作者:
[Williams MB, Palmer JW, Chehade SB, Hall AJ, Barry RJ, Powell ML, Harris ML, Sun LY, Watts SA]
通讯作者:
Watts SA
DOI:
10.18632/aging.204484
发表时间:
2023-01-13
期刊:
AGING-US
影响因子:
5.2
作者:
[Nagarajan, Akash, Srivastava, Hemant, Morrow, Casey D., Sun, Liou Y.]
通讯作者:
Sun, Liou Y.
Lifespan extension, Somatotropic signaling and Tauopathy
-
批准号:10661340
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2023
-
负责人:Liou Sun
-
依托单位:
Longevity assurance interventions, metabolic health and Alzheimer's Disease
-
批准号:9761415
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2018
-
负责人:Liou Sun
-
依托单位:
Longevity assurance interventions, metabolic health and Alzheimer's Disease
-
批准号:10200629
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2018
-
负责人:Liou Sun
-
依托单位:
Longevity assurance interventions, metabolic health and Aβ toxicity
-
批准号:9561312
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2017
-
负责人:Liou Sun
-
依托单位:
The effects of early life nutritional and hormonal signals on mammalian aging
-
批准号:9222182
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2016
-
负责人:Liou Sun
-
依托单位:
The effects of early life nutritional and hormonal signals on mammalian aging
-
批准号:9068735
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2016
-
负责人:Liou Sun
-
依托单位:
The effects of early life nutritional and hormonal signals on mammalian aging (Health Disparities Admin Supp)
-
批准号:9132438
-
项目类别:
-
资助金额:$4.91万
-
财政年份:2014
-
负责人:Liou Sun
-
依托单位:
The effects of early life nutritional and hormonal signals on mammalian aging
-
批准号:8762628
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2014
-
负责人:Liou Sun
-
依托单位:
The effects of early life nutritional and hormonal signals on mammalian aging
-
批准号:8927526
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2014
-
负责人:Liou Sun
-
依托单位:
海外基金